When this happens, patients typically have to start over from the lowest original dose and escalate doses all over again, since stopping the regimen and going back to a higher dose commonly leads to adverse events, and patients may have reduced glycemic control during this time
However, it is important to recognise that GLP-1 receptors are present on some immune cells , including macrophages and lymphocytes
Do not aspirate before injecting
research-subject intestinal glutathione S-transferases
Some require immediate attention: Severe, persistent abdominal pain (could be pancreatitis) Signs of dehydration (dark urine, extreme dizziness, cant keep fluids down) Vision changes Severe allergic reactions (throat swelling, difficulty breathing) Continuous vomiting that prevents eating or taking medication Upper right abdominal pain with yellowing skin (gallbladder issues) Dehydration from GI side effects can cause kidney problems